Combination of trauma and drug as a treatment for implantation failure
Not Applicable
- Conditions
- Female infertility.Female infertility
- Registration Number
- IRCT2013072412146N2
- Lead Sponsor
- Vice chancellor for research, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 76
Inclusion Criteria
patients with two or more implantation failure in IVF; to be 18 to 40 years old; not to suffer from any systemic disease such as diabetes, hypertension, etc.)
Exclusion criterion: occurrence of intolerable adverse effects.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pregnancy. Timepoint: 10 days after in vitro fertilization. Method of measurement: Sending blood sample to laboratory to measure Beta HCG level.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie endometrial local injury and GnRH agonist effects in recurrent implantation failure?
How does the combination of endometrial injury and GnRH agonist compare to standard IVF protocols in improving pregnancy rates for recurrent implantation failure?
Which biomarkers are associated with endometrial receptivity and response to GnRH agonist in patients with recurrent implantation failure?
What are the potential adverse events of endometrial local injury combined with GnRH agonist in infertility treatment?
Are there alternative combination therapies involving GnRH agonists or endometrial stimulation for recurrent implantation failure?